L&G Healthcare Breakthrough UCITS ETF USD Acc

ISIN IE00BK5BC677

 | 

WKN A2PM51

TER
0.49% p.a.
Distribution policy
Accumulating
Replication
Full replication
Fund size
70 m
Holdings
68
 

Overview

Trade this ETF at your broker

Choose your broker
Ad
Broker tip: Trade this ETF for 0.99€ per Order at the Scalable broker or for free in a savings plan. Find out more

Description

The L&G Healthcare Breakthrough UCITS ETF USD Acc seeks to track the ROBO Global Healthcare Technology and Innovation index. The ROBO Global Healthcare Technology and Innovation index tracks the performance of companies that are actively engaged in the healthcare technology value-chain.
 
The ETF's TER (total expense ratio) amounts to 0.49% p.a.. The L&G Healthcare Breakthrough UCITS ETF USD Acc is the only ETF that tracks the ROBO Global Healthcare Technology and Innovation index. The ETF replicates the performance of the underlying index by full replication (buying all the index constituents). The dividends in the ETF are accumulated and reinvested in the ETF.
 
The L&G Healthcare Breakthrough UCITS ETF USD Acc is a small ETF with 70m Euro assets under management. The ETF was launched on 2 July 2019 and is domiciled in Ireland.
Show more Show less

Chart

Basics

Data

Fund size
EUR 70 m
Total expense ratio
0.49% p.a.
Replication Physical (Full replication)
Legal structure ETF
Strategy risk Long-only
Fund currency USD
Currency risk Currency unhedged
Volatility 1 year (in EUR)
18.70%
Inception/ Listing Date 2 July 2019
Distribution policy Accumulating
Distribution frequency -
Fund domicile Ireland
Fund Provider Legal & General (LGIM)
Tax data Bundesanzeiger
Germany 30% tax rebate
Switzerland No ESTV Reporting
Austria Tax Reporting Fund
UK UK Reporting
Indextype Total return index
Swap counterparty -
Collateral manager BNY Mellon Fund Services (Ireland) Limited
Securities lending No
Securities lending counterparty

Similar ETFs

This section provides you with information on other ETFs with a similar investment focus to the L&G Healthcare Breakthrough UCITS ETF USD Acc.
Similar ETFs via ETF search
How do you like our new ETF profile? Here you'll find our Questionnaire.

Holdings

Below you find information about the composition of the L&G Healthcare Breakthrough UCITS ETF USD Acc.

Top 10 Holdings

Weight of top 10 holdings
out of 68
20.16%
Azenta
2.18%
Arrowhead Pharmaceuticals
2.13%
iRhythm Technologies
2.08%
Illumina
2.08%
Moderna, Inc.
2.03%
Intuitive Surgical
2.01%
Catalent
1.99%
Stryker
1.91%
Revvity
1.90%
Lonza Group AG
1.85%

Countries

United States
81.25%
Switzerland
4.61%
Italy
1.65%
Netherlands
1.64%
Other
10.85%
Show more

Sectors

Health Care
93.87%
Technology
1.29%
Consumer Discretionary
0.89%
Basic Materials
0.80%
Other
3.15%
As of 31/01/2024

ETF Savings plan offers

Here you can find information about the savings plan availability of the ETF. You can use the table to compare all savings plan offers for the selected savings rate.
 
Broker Rating Savings plan offer Brokerage fee More information
free of charge
free of charge
More info
free of charge
free of charge
More info
free of charge
free of charge
More info
free of charge
free of charge
More info
EUR 1.50
1.50%
free of charge
More info
Show all offers

Performance

Returns overview

YTD +3.72%
1 month +1.40%
3 months +3.03%
6 months +9.57%
1 year -0.46%
3 years -27.66%
5 years -
Since inception (MAX) +24.77%
2023 -6.26%
2022 -29.18%
2021 +8.52%
2020 +51.67%

Monthly returns in a heat map

Risk

Risk metrics in this section:
 
  • Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
  • Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
  • Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
ETF returns include dividend payments (if applicable).
Show more Show less

Risk overview

Volatility 1 year 18.70%
Volatility 3 years 24.76%
Volatility 5 years -
Return per risk 1 year -0.02
Return per risk 3 years -0.41
Return per risk 5 years -
Maximum drawdown 1 year -25.97%
Maximum drawdown 3 years -50.52%
Maximum drawdown 5 years -
Maximum drawdown since inception -50.89%

Rolling 1 year volatility

Stock exchange

Listings

Listing Trade Currency Ticker Bloomberg /
iNAV Bloomberg Code
Reuters RIC /
iNAV Reuters
Market Maker
gettex EUR XMLH -
-
-
-
-
Borsa Italiana EUR DOCT DOCT IM
DOCEURIV
DOCT.MI
DOCTEURINAV=SOLA
Flow Traders B.V.
London Stock Exchange GBX DOCG DOCG LN
NA
DOCG.L
NA
Flow Traders B.V.
London Stock Exchange USD DOCT DOCT LN
NA
DOCT.L
NA
Flow Traders B.V.
SIX Swiss Exchange CHF DOCT DOCT SW
DOCEURIV
DOCT.S
Flow Traders B.V.
XETRA EUR XMLH XMLH GY
DOCEURIV
DOCT.DE
Flow Traders B.V.

Further information

Further ETFs with similar investment focus

Fund name Fund Size in m € (AuM) TER
in % p.a.
Distribution policy Replication method
iShares Healthcare Innovation UCITS ETF 1,056 0.40% p.a. Accumulating Sampling
L&G Pharma Breakthrough UCITS ETF 20 0.49% p.a. Accumulating Full replication
HANetf HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF 16 0.59% p.a. Accumulating Full replication
VanEck Genomics and Healthcare Innovators UCITS ETF A 7 0.35% p.a. Accumulating Full replication
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C 3 0.30% p.a. Accumulating Full replication

Frequently asked questions

What is the name of XMLH?

The name of XMLH is L&G Healthcare Breakthrough UCITS ETF USD Acc.

What is the ticker of L&G Healthcare Breakthrough UCITS ETF USD Acc?

The primary ticker of L&G Healthcare Breakthrough UCITS ETF USD Acc is XMLH.

What is the ISIN of L&G Healthcare Breakthrough UCITS ETF USD Acc?

The ISIN of L&G Healthcare Breakthrough UCITS ETF USD Acc is IE00BK5BC677.

What are the costs of L&G Healthcare Breakthrough UCITS ETF USD Acc?

The total expense ratio (TER) of L&G Healthcare Breakthrough UCITS ETF USD Acc amounts to 0.49% p.a.. These costs are withdrawn continuously from the fund assets and already included in the performance of the ETF. You don't have to pay them separately. Please have a look at our article for more information about the cost of ETFs.

Is L&G Healthcare Breakthrough UCITS ETF USD Acc paying dividends?

L&G Healthcare Breakthrough UCITS ETF USD Acc is an accumulating ETF. This means that dividends are not distributed to investors. Instead, dividends are reinvested in the fund on the ex-date, which leads to an increase of the ETF's share price.

What's the fund size of L&G Healthcare Breakthrough UCITS ETF USD Acc?

The fund size of L&G Healthcare Breakthrough UCITS ETF USD Acc is 70m Euro. See the following article for more information about the size of ETFs.

Track your ETF strategies online

— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.